For construction of the recombinant lentiviruses that expresses specific shRNAs against MECOM or PU.1, the targeted sequences (see S2 Table) were synthesized and inserted into the pLentiLox 3.7-RNAi plasmid (Invitrogen) following the manufacturer’s protocols. For construction of the recombinant lentivirus that expresses miR-22, a 300-bp DNA fragment containing the miR-22 precursor was amplified and inserted into pMiRNA1 vector. The miRZip lentivector construct expressing miRZip shRNAs targeting miR-22 (Lenti-ZIP-miR-22) was purchased from SBI (Mountain View, CA, USA). The virus packaging was performed using a packaging kit from SBI (Mountain View) according to the manufacturer’s instructions. The lentivirus particles (Lenti-miR-22, Lenti-Con, Lenti-ZIP-miR-22, Lenti-ZIP-Con, shMECOM, shPU.1, shCon) were harvested and concentrated using PEG-it Virus Precipitation Solution (SBI). The lentiviral particles were added into the THP1 cells or CD34+ cells in the presence of Polybrene (5 μg/mL; Sigma, St. Louis, MO, USA). The cells were washed with PBS 24 hours after infection and exposed to lineage-specific differentiation cultures or plated for colony-forming assay.
+ Open protocol